Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
HK Stock MarketDetailed Quotes
BIOCYTOGEN-B (02315)
- 52.400
- +2.200+4.38%
Market Closed Apr 30 16:07 CST
23.42BMarket Cap71.20P/E (TTM)
53.400High49.260Low1.09MVolume50.200Open50.200Prev Close57.05MTurnover0.98%Turnover Ratio122.14P/E (Static)446.90MShares70.15052wk High9.06P/B5.80BFloat Cap11.60052wk Low--Dividend TTM110.78MShs Float70.150Historical High--Dividend LFY8.25%Range %5.600Historical Low52.318Avg Price500Lot Size--Div Yield TTM--Div Yield LFY
BIOCYTOGEN-B (02315) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 337.89%188.03M | ---- | ---- | 111.30%42.94M | ---- | 36.78%-380.16M | ---- | -10.21%-601.35M | ---- |
| Profit adjustment | ||||||||||
| Attributable subsidiary (profit) loss | ---- | -25.03%22.31M | ---- | ---- | 196.73%29.75M | ---- | -32.11%10.03M | ---- | 3,574.13%14.77M | ---- |
| Impairment and provisions: | ---- | 76.48%27.41M | ---- | ---- | 13.33%15.53M | ---- | 184.97%13.7M | ---- | -2.30%4.81M | ---- |
| -Impairmen of inventory (reversal) | ---- | 150.02%15.34M | ---- | ---- | -34.90%6.13M | ---- | 178.18%9.42M | ---- | 87.44%3.39M | ---- |
| -Impairment of trade receivables (reversal) | ---- | 28.48%12.07M | ---- | ---- | 119.45%9.4M | ---- | 201.13%4.28M | ---- | -54.35%1.42M | ---- |
| Revaluation surplus: | ---- | -379.92%-65.9M | ---- | ---- | -173.09%-13.73M | ---- | 75.80%-5.03M | ---- | -83.57%-20.78M | ---- |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.41M | ---- |
| -Other fair value changes | ---- | -379.92%-65.9M | ---- | ---- | -173.09%-13.73M | ---- | 78.32%-5.03M | ---- | -104.89%-23.19M | ---- |
| Asset sale loss (gain): | ---- | -602.68%-787K | ---- | ---- | 93.89%-112K | ---- | 92.77%-1.83M | ---- | -2,404.45%-25.35M | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---25.43M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -9,737.50%-787K | ---- | ---- | 99.56%-8K | ---- | -2,334.15%-1.83M | ---- | 121.30%82K | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---104K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -5.16%160.46M | ---- | ---- | -7.27%169.18M | ---- | 4.79%182.45M | ---- | 35.91%174.1M | ---- |
| -Amortization of intangible assets | ---- | -3.72%7.4M | ---- | ---- | 0.08%7.69M | ---- | 150.67%7.68M | ---- | 89.67%3.07M | ---- |
| Financial expense | ---- | -22.55%71M | ---- | ---- | -8.18%91.68M | ---- | 77.85%99.84M | ---- | 42.39%56.14M | ---- |
| Exchange Loss (gain) | ---- | 69.82%-1.79M | ---- | ---- | 15.63%-5.92M | ---- | 57.64%-7.02M | ---- | -1,032.88%-16.57M | ---- |
| Special items | ---- | 55.64%35.24M | ---- | ---- | 6.57%22.64M | ---- | 38.74%21.25M | ---- | -44.82%15.31M | ---- |
| Operating profit before the change of operating capital | ---- | 23.87%435.97M | ---- | ---- | 627.14%351.96M | ---- | 83.26%-66.77M | ---- | -12.18%-398.91M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -1.94%-13.18M | ---- | ---- | -440.77%-12.93M | ---- | 159.28%3.79M | ---- | 78.64%-6.4M | ---- |
| Accounts receivable (increase)decrease | ---- | 14.96%-82.22M | ---- | ---- | -147.79%-96.68M | ---- | -749.44%-39.02M | ---- | 87.19%-4.59M | ---- |
| Accounts payable increase (decrease) | ---- | 268.86%71.8M | ---- | ---- | -202,376.19%-42.52M | ---- | -100.02%-21K | ---- | 59.31%88.27M | ---- |
| prepayments (increase)decrease | ---- | -171.66%-18.93M | ---- | ---- | -142.59%-6.97M | ---- | -48.37%16.36M | ---- | 363.41%31.69M | ---- |
| Special items for working capital changes | ---- | -122.73%-6.3M | ---- | ---- | 187.19%27.7M | ---- | 172.44%9.65M | ---- | -208.51%-13.32M | ---- |
| Cash from business operations | ---- | 75.53%387.15M | 571.51%219.48M | ---- | 390.19%220.56M | 286.03%32.68M | 74.94%-76.01M | 84.19%-17.57M | 17.09%-303.27M | 28.98%-111.16M |
| Other taxs | ---- | -81.40%-16.9M | -421.49%-16.04M | ---- | -1,355.63%-9.32M | ---3.08M | 20.40%-640K | ---- | ---804K | ---- |
| Special items of business | 325.80%144.88M | ---- | ---- | --34.03M | ---- | ---- | ---- | ---- | --804K | ---- |
| Net cash from operations | 325.80%144.88M | 75.27%370.25M | 587.09%203.43M | --34.03M | 375.62%211.25M | 268.52%29.61M | 74.73%-76.65M | 84.19%-17.57M | 17.09%-303.27M | 28.98%-111.16M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | --615.05K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | --82.11M | ---51.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | 48.48%31.82K | -73.67%291K | 7.19%298K | --21.43K | -95.80%1.11M | 19.83%278K | 1,511.01%26.34M | 172.94%232K | -65.63%1.64M | -93.06%85K |
| Purchase of fixed assets | -840.45%-106.05M | -136.52%-87.82M | -41.41%-31.72M | ---11.28M | 70.68%-37.13M | 75.14%-22.43M | 47.30%-126.62M | 33.74%-90.24M | -20.94%-240.27M | -10.65%-136.2M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.86M | ---6.86M |
| Recovery of cash from investments | --399.38M | 93.55%16.88M | ---- | ---- | --8.72M | ---- | ---- | ---- | -84.38%101.46M | -39.60%100M |
| Cash on investment | ---704.51M | -78.78%-196.32M | ---- | ---- | ---109.81M | ---9.81M | ---- | ---- | 98.20%-9.71M | ---- |
| Other items in the investment business | ---100M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -4,435.92%-510.53M | -34.82%-184.86M | -159.35%-82.9M | ---11.26M | -36.73%-137.12M | 64.49%-31.96M | 34.77%-100.28M | -109.48%-90.01M | -82.74%-153.74M | 86.42%-42.97M |
| Net cash before financing | -1,705.87%-365.65M | 150.08%185.39M | 5,216.13%120.54M | --22.77M | 141.90%74.13M | 97.81%-2.36M | 61.29%-176.92M | 30.20%-107.58M | -1.58%-457M | 67.40%-154.13M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 97.62%215.94M | 5.35%248.27M | 12.83%182.27M | --109.27M | -26.33%235.67M | 42.50%161.55M | 52.63%319.91M | 98.15%113.37M | --209.6M | --57.22M |
| Refund | -134.84%-232.02M | -29.42%-343.42M | -51.31%-233.38M | ---98.8M | 8.57%-265.35M | -166.85%-154.24M | -867.80%-290.21M | -1,053.92%-57.8M | ---29.99M | 86.52%-5.01M |
| Interest paid - financing | ---- | 0.83%-31.02M | 1.98%-15.07M | ---- | -29.90%-31.28M | -54.02%-15.37M | -41.66%-24.08M | -173.72%-9.98M | -121.83%-17M | 3.49%-3.65M |
| Dividends paid - financing | 7.85%-3.54M | ---- | ---- | ---3.84M | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | --1.17B | ---- | ---- | ---- | ---- | ---- | ---- | 67.52%521.06M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | -2,339.55%-20.42M | -7.45%-519K | ---- | 92.23%-837K | 81.20%-483K | 53.08%-10.77M | 73.25%-2.57M | 14.36%-22.96M | ---9.6M |
| Pledged bank deposit (increase) decrease | ---- | ---- | --3.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -1,214.48%-296.54M | -90.67%-14.98M | -2,525.46%-10M | ---22.56M | 25.23%-7.86M | 95.60%-381K | 79.77%-10.51M | 42.86%-8.67M | -23.21%-51.94M | ---15.17M |
| Net cash from financing operations | -1,884.54%-316.16M | 1,164.73%979.86M | -548.23%-87.28M | ---15.93M | -143.34%-92.03M | -162.60%-13.47M | -106.44%-37.82M | 79.86%21.51M | 167.59%587.2M | -95.12%11.96M |
| Effect of rate | -811.13%-6.56M | 3.53%2.84M | 62.49%3.36M | --921.88K | -20.79%2.75M | -79.23%2.07M | -75.65%3.47M | 31.72%9.95M | 3,847.63%14.24M | 164.76%7.55M |
| Net Cash | -10,070.41%-681.82M | 6,611.25%1.17B | 310.18%33.25M | --6.84M | 91.67%-17.9M | 81.62%-15.82M | -264.94%-214.74M | 39.46%-86.07M | 156.49%130.2M | 37.52%-142.17M |
| Begining period cash | 303.83%1.55B | -3.79%384.46M | -3.79%384.46M | --384.46M | -34.59%399.61M | -34.59%399.61M | 30.97%610.88M | 30.97%610.88M | -33.11%466.45M | -33.11%466.45M |
| Cash at the end | 120.33%864.18M | 303.83%1.55B | 9.13%421.07M | --392.22M | -3.79%384.46M | -27.85%385.85M | -34.59%399.61M | 61.16%534.76M | 30.97%610.88M | -29.79%331.83M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | IAS | CAS (2007) | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | KPMG | -- | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"